Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

A new study suggests that semaglutide, a drug commonly used to treat diabetes, may help protect the brain from the effects of ...

Here’s the short version: Compounded semaglutide isn’t approved by the FDA (U.S. Food and Drug Administration), so it hasn’t been proven effective in clinical trials. However, it contains ...

For years, people taking GLP-1 type drugs (e.g., Ozempic, Wegovy) have noticed that the medicines didn’t just help them to ...

Scientists are trying to tackle Alzheimer's from all angles, and a new study adds to the growing evidence that semaglutide, a ...

Current research findings and clinical trials have highlighted the efficacy of semaglutide beyond diabetes management and cautioned physicians on certain side effects of this medicine. Researchers ...

Semaglutide shows promise in reducing alcohol cravings and consumption. Could it be a future treatment for AUD?

Researchers analysed data from 150 adults with T1D, divided into semaglutide ... therapies for T1D could spur formal clinical trials aimed at regulatory approval for these drugs in T1D, opening ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that ... lower than has been achieved in clinical trials of Eli Lilly's rival obesity therapy ...

there was a significant treatment-by-time interaction indicating that semaglutide treatment predicted greater relative reductions in cigarettes per day (β, −0.10). “Should additional phase 2 and phase ...

The use of GLP-1 receptor agonists, like semaglutide, to treat type 2 diabetes is not associated with an increased risk of ...